Adjuvant chemotherapy for epithelial ovarian cancer (EOC)

被引：0
|
作者：
Kumar, Lalit [1 ]
Prasad, Roopa Hari [1 ]
Sengar, Manju [1 ]
机构：
[1] All India Inst Med Sci, Inst Rotary Canc Hosp, Dept Med Oncol, New Delhi 110029, India
来源：
INDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGY | 2006年 / 27卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：4 / 5
页数：2
相关论文
共 50 条
  • [21] Chemotherapy in epithelial ovarian cancer
    Pignata, Sandro
    Cannella, Lucia
    Leopardo, Davide
    Pisano, Carmela
    Bruni, Giovanni Salvatore
    Facchini, Gaetano
    [J]. CANCER LETTERS, 2011, 303 (02) : 73 - 83
  • [22] Early Stage Epithelial Ovarian Cancer (EOC): AIIMS Experience
    Hariprasad, Roopa
    Kumar, S.
    Bhatla, N.
    Thulkar, S.
    Dawar, R.
    Vijayraghwan, M.
    Kumar, Lalit
    [J]. INDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGY, 2009, 30 (05) : 13 - 13
  • [23] Chemotherapy in epithelial ovarian cancer
    Tazi, Y.
    Pautier, P.
    Leary, A.
    Lhomme, C.
    [J]. GYNECOLOGIE OBSTETRIQUE & FERTILITE, 2013, 41 (10): : 611 - 616
  • [24] International phase III trials in epithelial ovarian cancer (EOC)
    McGuire, William P.
    [J]. CANCER INVESTIGATION, 2007, 25 : 28 - 28
  • [25] Is there a survival benefit for patients who receive post-operative adjuvant chemotherapy following secondary cytoreductive surgery (SCRS) for recurrent epithelial ovarian cancer (EOC)?
    Kolomainen, D.
    Butler, J.
    Barton, D. P. J.
    Taylor, A.
    Stanley, K.
    Gore, M.
    Banerjee, S.
    [J]. EUROPEAN JOURNAL OF CANCER, 2015, 51 : S550 - S550
  • [26] IS THERE A SURVIVAL BENEFIT FOR PATIENTS WHO RECEIVE POST-OPERATIVE ADJUVANT CHEMOTHERAPY FOLLOWING SECONDARY CYTOREDUCTIVE SURGERY (SCRS) FOR RECURRENT EPITHELIAL OVARIAN CANCER (EOC)?
    Kolomainen, D. F.
    Butler, J.
    Barton, D. P. J.
    Ind, T. E. J.
    Nobbenhuis, M. A. E.
    Lalondrelle, S.
    Taylor, A.
    Shepherd, J. H.
    Gore, M. E.
    Kaye, S. B.
    Banerjee, S.
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2015, 25 (09) : 1407 - 1407
  • [27] BRCA1 protein expression as a predictor of outcome following chemotherapy in sporadic epithelial ovarian cancer (EOC)
    Carser, J. E.
    Quinn, J. E.
    Michie, C. O.
    McCluggage, W. G.
    Williams, A. R.
    Mullan, P. B.
    Gourley, C. M.
    Harkin, D. P.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [28] Utility of Gene Promoter Methylation in Prediction of Response to Platinum-Based Chemotherapy in Epithelial Ovarian Cancer (EOC)
    Chaudhry, Parvesh
    Srinivasan, Radhika
    Patel, Firuza D.
    [J]. CANCER INVESTIGATION, 2009, 27 (08) : 877 - 884
  • [29] POST-OPERATIVE ADJUVANT RADIOTHERAPY FOLLOWING SECONDARY CYTOREDUCTIVE SURGERY (SCRS) FOR RECURRENT EPITHELIAL OVARIAN CANCER (EOC)
    Kolomainen, D.
    Butler, J.
    Barton, D.
    Taylor, A.
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2016, 26 : 743 - 743
  • [30] Characterization of breast cancer resistance protein (BCRP) in epithelial ovarian cancer (EOC)
    Sayer, R
    Turner, J
    Sullivan, D
    Fiorica, J
    Lancaster, J
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 140S - 140S
12345